Envoy Medical, Inc. (COCH) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Envoy Medical, Inc. (NASDAQ:COCH) is held by 24 institutional firms.

• These investors collectively held 6.1% of the company's total shares outstanding in December 2025, down from 10.9% in September 2025.
• The company experienced a 37.52% quarterly change in institutional shares held, alongside a decrease of 7.69% in total owners annually.
• The latest 13F cycle for Envoy Medical reveals that of 24 total investors, 12 funds grew their exposure, whereas 4 reduced theirs and 8 made no changes.
• Collectively, institutional investors increased their stake in Envoy Medical to 1.23Mn shares as of December 2025, a change that is up by 334.47K shares quarter on quarter and down 799.05K shares year over year.
• The top institutional stake in Envoy Medical as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 347.30K shares, or 1.72% of the company.
• Among the most significant buyers of Envoy Medical during December 2025 were SUSQUEHANNA INTERNATIONAL GROUP, LLP (119.11K), CITADEL ADVISORS LLC (88.44K), GEODE CAPITAL MANAGEMENT, LLC (51.81K), TWO SIGMA SECURITIES, LLC (27.66K), Vanguard Personalized Indexing Management, LLC (19.02K).
• Leading sellers of Envoy Medical stock in December 2025 included Tower Research Capital LLC (TRC) (552), WELLS FARGO & COMPANY/MN (200), CITIGROUP INC (70), BANK OF AMERICA CORP /DE/ (5).
• The top 10 institutional holders of Envoy Medical for the quarter ending December 2025 included VANGUARD GROUP INC (347.30K), Focus Partners Wealth (212.66K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (119.11K), GEODE CAPITAL MANAGEMENT, LLC (98.35K), CITADEL ADVISORS LLC (88.44K), CIBC Private Wealth Group LLC (77.89K), MORGAN STANLEY (57.10K), BlackRock, Inc. (39.91K), LPL Financial LLC (28.40K), METEORA CAPITAL, LLC (28.05K).